1. <div id="8sgz1"><ol id="8sgz1"></ol></div>

        <em id="8sgz1"><label id="8sgz1"></label></em>
      2. <em id="8sgz1"><label id="8sgz1"></label></em>
        <em id="8sgz1"></em>
        <div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

        <button id="8sgz1"></button>
        west china medical publishers
        Keyword
        • Title
        • Author
        • Keyword
        • Abstract
        Advance search
        Advance search

        Search

        find Keyword "凝血功能" 22 results
        • Changes on Perioperative Coagulation Function of Orthotopic Liver Transplantation inPatients with Advancing Chronic Hepatopathy and Fulminant Hepatitis

          目的 比較進展性慢性肝病及重癥肝炎患者原位肝移植(OLT)圍手術期凝血功能的變化。方法 回顧性分析我中心2004年1月至2005年12月期間行OLT治療進展性慢性肝病及重癥肝炎患者各37例的圍手術期血小板(PLT)、凝血酶原時間(PT)、活化部分凝血活酶時間(APTT)及纖維蛋白原(FIB)的變化。結果 2組患者除術前PT、APTT,術后第5 d PLT、FIB和術后第7 d FIB的差異有統計學意義外(plt;0.05),其余時段2組患者的PLT、PT、APTT及FIB 間差異均無統計學意義(Pgt;0.05), 提示重癥肝炎患者凝血功能損害更為嚴重; OLT術后,2組患者的凝血功能均逐漸恢復正常, 但并非完全同步。結論 進展性慢性肝病與重癥肝炎患者OLT圍手術期凝血功能變化顯著,應注意監測及處理,但術后2組間各指標間比較差異并不明顯。

          Release date:2016-09-08 11:07 Export PDF Favorites Scan
        • Paroxysmal Acquired Coagulopathy Caused by Anticoagulant Rodenticides: A Report of Three Cases and the Literature Review

          目的 分析反復發作的抗凝血類滅鼠藥所致獲得性凝血功能障礙的臨床特點,探討其診治方案。方法 對2009年3月-2010年12月收治的3例抗凝血類滅鼠藥所致獲得性凝血功能障礙患者的臨床表現、實驗室檢查和治療轉歸進行分析,并復習相關文獻。 結果 3例患者均以同時出現多部位出血為首發表現,經應用維生素K1、凝血酶原復合物、新鮮冰凍血漿、冷沉淀等治療,患者病情好轉,實驗室指標恢復正常。停藥(2、5周,3個月)后再次出現多部位出血,再給予維生素K1等治療,病情可緩解。 結論 維生素K1可作為首選的治療藥物,且對反復發作的患者同樣有效。為避免再發性出血,應維持治療至少3個月。

          Release date: Export PDF Favorites Scan
        • 地震致顱腦傷患者早期血凝機制探討

          【摘要】 目的 總結地震致顱腦傷患者凝血功能及疾病嚴重程度判別的臨床意義。 方法 2008年5月12-30日,對收治的地震致顱腦傷患者按GCS評分分為Ⅰ、Ⅱ、Ⅲ組,Ⅰ組:13~15分10例;Ⅱ組:9~12分21例;Ⅲ組:3~8分9例;另擇單純軟組織挫傷患者9例為對照組,分別檢測凝血酶原時間(PT)、活化部分凝血活酶時間(APTT)、凝血酶時間(TT)、纖維蛋白原(FIB)及血小板的指標。 結果 顱腦傷組PT、APTT、TT、FIB、血小板與對照組比較差異有統計學意義;其凝血功能異常變化與疾病嚴重程度相關。 結論 檢測PT、APTT、TT、FIB及血小板變化可以了解顱腦地震傷者的凝血功能及判斷疾病的嚴重程度,有助于顱腦地震傷患者的診斷和治療。

          Release date:2016-08-26 02:21 Export PDF Favorites Scan
        • The blood clotting dysfunction and therapeutic efect of low molecular hepa~n in a mouse model of invasive pulmonary aspergillosi

          Objective To investigate the blood clotting dysfunction of invasive pulmonary aspergillosis(IPA)and the therapeutic effect of low molecular hepafin in a mouse model.Methods The neutropenic IPA mouse model was constructed by being given cyclophosphamide to depress immunologic function,and then intranasally challenged with Aspergillus fumigatus conidia.(1)Blood clotting function were assessed by bleeding time,clotting time,platelet count and antithrombase-III(AT-III)activity.Seventy-two mice were randomly assigned into 4 groups.Group A received only normal saline.group B received normal saline to substitute the cycloph0sphamide,and the rest equal to group D.Group C received normal saline to substitute the AspergiUus fumigatus conidia suspension,and the rest equal to group D.Group D(model group)received cyclophosphamide(intraperitoneally,150 mg/kg,d4,d1)and Aspergillus fumigatus conidia suspension(intranasally,40 μL/mouse,1.5×10∧5/mL,d0).Six mice were randomly sacrificed in each group for analysis of blood clotting function per 24 h after inoculation for 3 times.(2)Therapeutic effect of low molecular heparin was determined by survival time of IPA mice.One hundred and eighteen mice were randomly assigned into 4 groups after challenged with 6×10 conidia/mouse and received one of the following regimens daily from dl to d7 after challenge,vehicle(group E,n=29),low molecular heparin(group F,n=30,subcutaneous injection,1000 IU/kg,qd×7 d),amphotericin B(group G,n=29,intraperitoneal,1 m kg,qd×7 d),low molecular heparin plus amphotericin B(group H,n=30).Mice survivals were recorded once daily to d21 after innoculation.Results (1)AT-III activity of group D decreased significantly 24 h after innoculation.Bleeding time and clotting time decreased significantly and AT—III activity decreased sequentially 48 h after innoculation.The platelet decreased significantly 72 h after innoculation,and bleeding time shoaened further.Clotting time was longer than that 0f 48 h.but still shorter than norm al and AT-III activity decreased sequentially.There were significant differences when comparing group D with group A,B and C(all Plt;0.01).And there was no significant difference between group A,B and C(all Pgt;0.05).(2)Survival analysis indicated that the therapeutic effect of low molecular hepafin plus amphotericin B was better than that of amphotericin B or low molecular heparin alone.No therapeutic effect was found in group F(group E vs group F,Pgt;0.05,both group E and group F compared with group H,P lt;0.01.Group H vs group G,P lt;0.05.Both group E and group F compared with group G,P lt;0.05).Conclusions The results suggest that there is blood clotting dysfunction in IPA mice and AT—III activity may be an early index to monitor the disfunction.Compared with the therapeutic effect of amphoterinein B alone,low molecular hepafin plus amphoterincin B can prolong survival of neutropenic IPA mice

          Release date:2016-09-14 11:57 Export PDF Favorites Scan
        • Liver Transplantation in Benign Liver Diseases

          肝臟移植作為終末期肝病的治療,自上個世紀80年代在歐美國家獲得公認以來,已在世界各國得到迅速開展。我國自90年代后期以來,在全國掀起了第二個肝移植的熱潮,迄今已完成1 000余例肝移植,在圍手術期處理、手術技術、介入放射、移植免疫、抗感染治療等各個方面均獲得豐富的經驗,我國肝移植的效果及長期生存率亦逐步趕上國際先進水平。總的來講,適合進行肝移植的病種可分為良性及惡性肝病,鑒于惡性肝病行肝移植后復發率高,長期生存率低,因而其作為肝移植的指征長期以來存在爭議,而良性終末期肝病則是肝移植的主要指征。我院自1999年2月以來連續施行肝移植114例,其中良性肝病為69例,占60.5%。本文僅針對良性肝病肝移植的一些特點談談我們的經驗和體會。

          Release date:2016-08-28 04:49 Export PDF Favorites Scan
        • Risk factors for coagulopathy after Stanford type A acute aortic dissection repair

          Objective To identify the risk factors for coagulopathy after Stanford type A acute aortic dissection (AAD) repair to offer evidence for improvement of patients' prognosis. Methods We retrospectively analyzed the clinical data of 95 patients undergoing Stanford type A AAD repair in Beijing Anzhen Hospital between January 2013 and December 2014. Patients with thromboelastography-coagulation index (TEG-CI) ≤–3 after surgery were allocated to a coagulopathy group (n=17, average age 48.70 years), whereas patients with TEG-CI >–3 after surgery were allocated to a control group ( n=78, average age 46.80 years). Multivariate analysis was used to identify risk factors for coagulopathy after surgery. Results Seventeen patients suffered from coagulopathy after surgery. Patients in the coagulopathy group had larger amount of fluid drainage than that in the control group (P=0.008). Risk factors for postoperative coagulopathy were activated partial thromboplastin time (APTT) at the end of surgery ( OR=0.011, 95% confidence interval 0.001 to 0.021, P=0.035), fibrinogen degradation products (FDP) at the end of surgery (OR=0.004, 95% confidence interval 0.001 to 0.007, P=0.022) and platelet count (×109/L) at the end of surgery (OR=–0.002, 95% confidence interval –0.003 to 0.000, P=0.049). The lower risk of postoperative coagulopathy was related to the platelet count at the end of surgery up to 137.00 ×109/L. Conclusion Postoperative coagulopathy could be related to the clinical and experimental variables. In a representative sample of Chinese adults undergoing Stanford type A AAD surgery, APTT, FDP and platelet count at the end of surgery are independent risk factors associated with postoperative coagulopathy. Adding haemostatic, such as fibrinogen and prothrombinase complex, is good for improving the recovery of coagulation function to reduce bleeding and postoperative blood transfusion, as well as adding platelet, plasma and other coagulation factors after AAD surgery.

          Release date:2018-07-27 02:40 Export PDF Favorites Scan
        • Correlations between Lipopolysaccharide, Phospholipase A2 and Platelet-activating Factor with Coagulopathy after Severe Chest and Abdominal Injuries and Their Mechanisms

          ObjectiveTo investigate the correlations between lipopolysaccharide(LPS), phospholipase A2 (PLA2) and platelet-activating factor (PAF) with coagulopathy after severe chest and abdominal injuries and their mechanisms. MethodsClinical data of 82 patients with severe chest and abdominal injuries whose trauma index (TI) was greater than or equal to 17 points in No. 253 Hospital of People's Liberation Army from January 2009 to June 2012 were retrospectively analyzed (severe chest and abdominal injury group). Those patients who had concomitant traumatic brain injuries or died in the Emergency Department were excluded from this study. There were 58 male and 24 female patients with their age of 16-76 (43.59±16.33)years. There were 17 patients with open injuries and 65 patients with closed injuries. There were 23 patients with fall injuries, 47 patients with traffic injuries, 8 patients with blunt force injuries, and 4 patients with penetrating injuries. Forty-two healthy volunteers who received routine medical examinations in the outpatient department of our hospital were chosen as the control group, including 27 males and 15 females with their age of 24-47 (37.32±10.45) years. Blood platelet (PLT) count, D-dimer (D-D), activated partial thromboplastin time (APTT), LPS, PLA2 and PAF were compared between the 2 groups, and linear correlation analysis was performed. ResultsPLT of the severe chest and abdominal injury group patients were significantly lower than that of the control group[(83.44±38.52)×109/L vs. (191.52±23.31)×109/L]. D-D[(1 823.89±608.02) U/L vs. (105.78±44.53) U/L], APTT [(68.24±24.12) s vs. (22.47±9.41) s], LPS[(438.66±106.02) U/L vs. (87.38±46.51) U/L], PLA2 [(41.35±14.26) ng/ml vs. (7.47±5.27)ng/ml] and PAF[(15 765.31±4 431.65) ng/L vs. (3 823.45±529.72) ng/L] of the severe chest and abdominal injury group patients were significantly higher than those of the control group(P < 0.001). PLT was significantly negatively correlated with LPS, PLA2 and PAF with all the respective correlation coefficient(r)less than-0.933 5. D-D and APTT were significantly positively correlated with LPS, PLA2 and PAF with all the respective r larger than 0.921 6. ConclusionLPS, PLA2 and PAF participate in the pathogenesis of coagulopathy in patients with severe chest and abdominal injuries. Early intervention against LPS, PLA2 and PAF may improve coagulopathy and survival rate of patients with severe chest and abdominal injuries.

          Release date: Export PDF Favorites Scan
        • A Study on the Correlation between Traumatic Coagulopathy and Traumatic Brain Injury

          目的:探討腦損傷患者凝血功能水平與顱腦損傷傷情轉歸的相關性。方法:收集70例顱腦損傷患者的臨床資料,傷者抽取靜脈血2 mL,進行凝血功能檢測,分析結果與臨床資料等分別采用SPSS 11.5軟件進行χ2檢驗和logistic回歸分析。結果:在13例凝血功能異常患者中有5例(38%)傷情加重(較入院時腦內血腫體積增大,遲發性血腫等),明顯高于凝血功能正常而傷情加重者(12%,Plt;0.05);單因素和多因素logistic回歸分析提示凝血功能異常時腦損傷傷情加重的危險因素。結論:腦創傷后凝血功能異常時顱腦損傷患者傷情加重的危險因素。

          Release date:2016-09-08 09:56 Export PDF Favorites Scan
        • Effects of intraoperative intermittent pneumatic compression on postoperative coagulation and fibrinolysis functions, lower extremity venous blood flow velocity, and deep vein thrombosis in patients with gastric cancer after radical gastrectomy

          ObjectiveTo investigate the effects of intraoperative intermittent pneumatic compression (IPC) treatment on coagulation and fibrinolysis, lower extremity venous blood flow velocity, and deep venous thrombosis (DVT) in patients with gastric cancer (GC) after radical gastrectomy. MethodsThe patients with GC who underwent radical gastrectomy at Hebei Provincial People’s Hospital from July 2021 to July 2024 were retrospectively enrolled, then the patients were assigned into control group (the patients who did not receive intraoperative IPC) and study group (the patients who received intraoperative IPC), and the propensity score matching (PSM) method was used to conduct 1∶1 matching based on the basic characteristics such as age, gender, body mass index, comorbidities to ensure baseline comparability between the two groups. The incidences of postoperative DVT and lower extremity swelling, and coagulations [prothrombin time (PT), thrombin time (TT), activated partial thromboplastin time (APTT)] and fibrinolysis [D-dimer (D-D), fibrinogen (FIB), and fibrin degradation products (FDP)], as well as lower extremity venous blood flow velocity were analyzed after PSM. The locally weighted regression was used to analyze the correlation between the coagulation and fibrinolytic functions indexes and the lower extremity venous blood flow velocity. ResultsA total of 120 patients were matched (60 cases per group). The baseline characteristics of both groups were comparable (P>0.05). The incidences of DVT on day 7 and lower extremity swelling on day 1, 3, and 7 after surgery in the study group were significantly lower than those in the control group (P<0.05). The results of repeated-measures analysis of variance showed that there were statistically significant differences in the inter-group, time-related, and group-by-time interaction effects of coagulation and fibrinolysis indexes as well as lower extrimety venous blood flow velocities (P<0.05). The impact of the time factor on coagulation and fibrinolysis indexes and lower extrimety venous blood flow velocities varied with intraoperative IPC intervention measures. After surgery, the PT, TT, APTT, and lower extrimety venous blood flow velocities in the study group first decreased and then increased as compared with those before surgery, and the decrease degree was smaller and the increase degree was larger than those in the control group. After surgery, the D-D, FIB, and FDP in the study group first increased and then decreased as compared with those before surgery, and the increase degree was smaller and the decrease degree was larger than those in the control group. Both PT and TT were significantly positively correlated with femoral vein blood flow velocity (r=0.21, P=0.042; r=0.22, P=0.040), and both also showed significant positive correlations with popliteal vein blood flow velocity (r=0.25, P<0.001; r=0.20, P=0.032). APTT was only significantly positively correlated with popliteal vein blood flow velocity (r=0.33, P<0.001). D-D was negatively correlated with the flow velocities of the femoral vein, external iliac vein, and popliteal vein (r=–0.23, P=0.012; r=–0.22, P=0.047; r=–0.37, P<0.001). Both FIB and FDP were negatively correlated with the flow velocity of the femoral vein (r=–0.23, P=0.036; r=–0.27, P=0.002). FIB was also negatively correlated with the flow velocity of the popliteal vein (r=–0.26, P=0.038), and FDP was negatively correlated with the flow velocity of the external iliac vein (r=–0.31, P<0.001). ConclusionBased on the results of this study, intraoperative IPC treatment could improve coagulation and fibrinolytic functions of patients with GC after surgery, and has a certain preventive effect on occurrence DVT of lower extremity.

          Release date:2025-04-21 01:06 Export PDF Favorites Scan
        • 抑肽酶對乙型病毒性肝炎患者體外循環術后凝血功能的影響

          目的探討抑肽酶對乙型病毒性肝炎(HB)患者體外循環(ECC)心臟手術凝血功能的影響. 方法 52例心臟病患者中,合并HB 33例,未合并HB 19例.33例合并HB患者隨機分為兩組,A組:17例,ECC中應用抑肽酶;B組:16例,ECC中不用抑肽酶;對照組:19例,為未合并HB患者,ECC中不用抑肽酶.動態監測所有患者的凝血因子Ⅺ促凝活性(FXI:C)、抗凝血酶Ⅲ活性(AT-Ⅲ:A)和D-二聚體的水平變化. 結果 A組術后出血量和輸血量明顯少于B組(P<0.01);術前3組患者FXI:C,AT-Ⅲ:A和D-二聚體組間比較差別均無顯著性意義(P>0.05);術后6小時、24小時,A組FXI:C明顯高于B組(P<0.05);3組間AT-Ⅲ:A差別無顯著性意義(P>0.05);ECC 20分鐘至術后24小時,A組D-二聚體明顯低于B組(P<0.01). 結論 HB患者ECC后存在較嚴重的凝血功能障礙;抑肽酶通過抑制繼發性纖溶功能亢進,減少凝血因子的消耗,從而減少HB患者的出血量和輸血量.

          Release date:2016-08-30 06:32 Export PDF Favorites Scan
        3 pages Previous 1 2 3 Next

        Format

        Content

          1. <div id="8sgz1"><ol id="8sgz1"></ol></div>

            <em id="8sgz1"><label id="8sgz1"></label></em>
          2. <em id="8sgz1"><label id="8sgz1"></label></em>
            <em id="8sgz1"></em>
            <div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

            <button id="8sgz1"></button>
            欧美人与性动交α欧美精品